vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»vsp-667Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWОсобенности поражения ЛОР-органов у детей с муковисцидозомPECULIARITIES OF ENT-DAMAGE IN CHILDREN WITH CYSTIC FIBROSISМартыноваИ.В.MartynovaI.V.ivmart@mail.ruКарповаЕ.П.KarpovaE.P.neonatepearl@yandex.ruКапрановН.И.KapranovN.I.neonatepearl@yandex.ruДетская городская клиническая больница No 13 им. Н.Ф. Филатова, МоскваFilatov Children’s City Hospital № 13, MoscowДетская городская клиническая больница No 7, МоскваChildren’s City Hospital № 7, Moscow201116092011105Вопросы современной педиатрии4953Copyright © Мартынова И., Карпова Е., Капранов Н., 20112011Мартынова И., Карпова Е., Капранов Н.Martynova I., Karpova E., Kapranov N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/667ReferencesKrzeski A., Kapiszewska-Dzedzej D., Gоrski N.P. et al. Cystic fibrosis in rhinologic practice. Am. J. Rhinol. 2002; 16 (3): 155–160.Krzeski A., Kapiszewska-Dzedzej D., Gоrski N.P. et al. Cystic fibrosis in rhinologic practice. Am. J. Rhinol. 2002; 16 (3): 155–160.Рачинский С.В., Таточенко В.К., Капранов Н.И. Муковисцидоз у детей. М.: Медицина. 1974.Рачинский С.В., Таточенко В.К., Капранов Н.И. Муковисцидоз у детей. М.: Медицина. 1974.Henriksson G., Westrin K.M., Karpati F. et al. Nasal polyps in cystic fibrosis: clinical endoscopic study with nasal lavage fluid analysis. Chest. 2002; 121 (1): 40–47.Henriksson G., Westrin K.M., Karpati F. et al. Nasal polyps in cystic fibrosis: clinical endoscopic study with nasal lavage fluid analysis. Chest. 2002; 121 (1): 40–47.Rozsasi A., Keck T. An update on cystic fibrosis for the ENT–specialist. Laryngorhinootologie. 2003; 82 (10): 715–25, 726–730.Rozsasi A., Keck T. An update on cystic fibrosis for the ENT–specialist. Laryngorhinootologie. 2003; 82 (10): 715–25, 726–730.Sorensen H., Mygind N., Tygstrup I. et al. Histology of nasal polyps of different etiology. Rhinology. 1977; 15 (3): 121–128.Sorensen H., Mygind N., Tygstrup I. et al. Histology of nasal polyps of different etiology. Rhinology. 1977; 15 (3): 121–128.Sobol S.E., Christodoulopoulos P., Manoukian J.J. et al. Cytokine profile of chronic sinusitis in patients with cystic fibrosis. Arch. Otolaryngol. Head. Neck. Surg. 2002; 128 (11): 1295–1298.Sobol S.E., Christodoulopoulos P., Manoukian J.J. et al. Cytokine profile of chronic sinusitis in patients with cystic fibrosis. Arch. Otolaryngol. Head. Neck. Surg. 2002; 128 (11): 1295–1298.Tos M., Mogensen C., Thomsen J. Nasal polyps in cystic fibrosis. J. Laryngol. Otol. 1977; 91 (10): 827–835.Tos M., Mogensen C., Thomsen J. Nasal polyps in cystic fibrosis. J. Laryngol. Otol. 1977; 91 (10): 827–835.Slieker M.G., Schilder A.G., Uiterwaal C.S. et al. Children with cystic fibrosis: who should visit the otorhinolaryngologist? Arch. Otolaryngol. Head. Neck. Surg. 2002; 128 (11): 1245–1248.Slieker M.G., Schilder A.G., Uiterwaal C.S. et al. Children with cystic fibrosis: who should visit the otorhinolaryngologist? Arch. Otolaryngol. Head. Neck. Surg. 2002; 128 (11): 1245–1248.Kapiszewska–Dzedzej D., Krzeski A., Held–Ziółkowska M. et al. Paranasal sinuses CT scans analysis of patients with cystic fibrosis. Otolaryngol. Pol. 2001; 55 (4): 383–388.Kapiszewska–Dzedzej D., Krzeski A., Held–Ziółkowska M. et al. Paranasal sinuses CT scans analysis of patients with cystic fibrosis. Otolaryngol. Pol. 2001; 55 (4): 383–388.Eggesbo H.B., Dolvik S., Stiris M. et al. Complementary role of MR imaging of ethmomaxillary sinus disease depicted at CT in cystic fibrosis. Acta Radiol. 2001; 42 (2): 144–150.Eggesbo H.B., Dolvik S., Stiris M. et al. Complementary role of MR imaging of ethmomaxillary sinus disease depicted at CT in cystic fibrosis. Acta Radiol. 2001; 42 (2): 144–150.Stern R.C., Boat T.F., Wood R.E. et al. Treatment and prognosis of nasal polyps in cystic fibrosis. Am. J. Dis. Child. 1982; 136 (12): 1067–1070.Stern R.C., Boat T.F., Wood R.E. et al. Treatment and prognosis of nasal polyps in cystic fibrosis. Am. J. Dis. Child. 1982; 136 (12): 1067–1070.Watelet J.B., van Cauwenberge P., Bachert C. Rhinological aspects of cystic fibrosis. Monaldi Arch. Chest. Dis. 2000; 55 (6): 475–477.Watelet J.B., van Cauwenberge P., Bachert C. Rhinological aspects of cystic fibrosis. Monaldi Arch. Chest. Dis. 2000; 55 (6): 475–477.Fokkens W., Lund V., Mullol J. et al. European position paper on rhinosinusitis and nasal polyps. Rhinology. 2007; 45 (Suppl. 20): 1–139.Fokkens W., Lund V., Mullol J. et al. European position paper on rhinosinusitis and nasal polyps. Rhinology. 2007; 45 (Suppl. 20): 1–139.Cepero R., Smith R.J., Catlin F.I. et al. Cystic fibrosis an otolaryngologic perspective. Otolaryngol. Head. Neck. Surg. 1987; 97: 356–360.Cepero R., Smith R.J., Catlin F.I. et al. Cystic fibrosis an otolaryngologic perspective. Otolaryngol. Head. Neck. Surg. 1987; 97: 356–360.Crockett D.M., McGill T.J., Healy G.B. et al. Nasal and paranasal sinus surgery in children with cystic fibrosis. Ann. Otol. Rhinol. Laryngol. 1987; 96 (4): 367–372.Crockett D.M., McGill T.J., Healy G.B. et al. Nasal and paranasal sinus surgery in children with cystic fibrosis. Ann. Otol. Rhinol. Laryngol. 1987; 96 (4): 367–372.Gysin C., Alothman G.A., Papsin B.C. Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management. Pediatr. Pulmonol. 2000; 30: 481–489.Gysin C., Alothman G.A., Papsin B.C. Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management. Pediatr. Pulmonol. 2000; 30: 481–489.Harvey R., Hannan S.A., Badia L. et al. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database of Systematic Reviews. 2008; issue 2. DOI: 10.1002/14651858.CD006394.pub2.Harvey R., Hannan S.A., Badia L. et al. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database of Systematic Reviews. 2008; issue 2. DOI: 10.1002/14651858.CD006394.pub2.Graf P.M. Rhinitis medicamentosa. Clin. Allergy Immunol. 2007; 19: 295–304.Graf P.M. Rhinitis medicamentosa. Clin. Allergy Immunol. 2007; 19: 295–304.Costantini D., Di Cicco M., Giunta A. et al. Nasal polyposis in cystic fibrosis treated by beclomethasone dipropionate. Acta Univ. Carol. 1990; 36: 220–221.Costantini D., Di Cicco M., Giunta A. et al. Nasal polyposis in cystic fibrosis treated by beclomethasone dipropionate. Acta Univ. Carol. 1990; 36: 220–221.Hadfield P.J., Rowe–Jones J.M., Mackay I.S. A prospective treatment trial of nasal polyps in adults with cystic fibrosis. Rhinology. 2000; 38: 63–65.Hadfield P.J., Rowe–Jones J.M., Mackay I.S. A prospective treatment trial of nasal polyps in adults with cystic fibrosis. Rhinology. 2000; 38: 63–65.Rowe–Jones J.M., Mackay I.S. Endoscopic sinus surgery in the treatment of cystic fibrosis with nasal polyposis. Laryngoscope. 1996; 106: 1540–1544.Rowe–Jones J.M., Mackay I.S. Endoscopic sinus surgery in the treatment of cystic fibrosis with nasal polyposis. Laryngoscope. 1996; 106: 1540–1544.Shwachman H., Kulczycki L.L., Mueller H.L. et al. Nasal polyposis in patients with cystic fibrosis. Pediatries. 1962; 30: 389–401.Shwachman H., Kulczycki L.L., Mueller H.L. et al. Nasal polyposis in patients with cystic fibrosis. Pediatries. 1962; 30: 389–401.Davidson T.M., Murphy C., Mitchell M. et al. Management of chronic sinusitis in cystic fibrosis. Laryngoscope. 1995; 105: 354–358.Davidson T.M., Murphy C., Mitchell M. et al. Management of chronic sinusitis in cystic fibrosis. Laryngoscope. 1995; 105: 354–358.Videler W.J., van Drunen C.M., Reitsma J.B. еt al. Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double blind, randomized, placebo controlled, cross over pilot study. Rhinology. 2008; 46: 92–98.Videler W.J., van Drunen C.M., Reitsma J.B. еt al. Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double blind, randomized, placebo controlled, cross over pilot study. Rhinology. 2008; 46: 92–98.Majima Y. Clinical implications of the immunomodulatory effects of macrolides on sinusitis. Am. J. Med. 2004; 117 (Suppl. 9A): 20–25.Majima Y. Clinical implications of the immunomodulatory effects of macrolides on sinusitis. Am. J. Med. 2004; 117 (Suppl. 9A): 20–25.Fuchs H.J., Borowitz D.S., Christiansen D.H. et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N. Engl. J. Med. 1994; 331: 637–642.Fuchs H.J., Borowitz D.S., Christiansen D.H. et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N. Engl. J. Med. 1994; 331: 637–642.Shah P.L., Conway S., Scott S.F. et al. A case controlled study with dornase alfa to evaluate impact on disease progression over a 4 year period. Respiration. 2001; 68: 160–164.Shah P.L., Conway S., Scott S.F. et al. A case controlled study with dornase alfa to evaluate impact on disease progression over a 4 year period. Respiration. 2001; 68: 160–164.Cimmino M., Tardone M., Cavaliere M. et al. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease. Arch. Otolaryngol. Head. Neck. Surg. 2005; 131: 1097–1101.Cimmino M., Tardone M., Cavaliere M. et al. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease. Arch. Otolaryngol. Head. Neck. Surg. 2005; 131: 1097–1101.Keller M., Schuschnig U., Knoch M. et al. Characterization of nebulized Pulmozyme® administered by the PARI SINUS™ utilizing a human cast model. NACF. 2006; 1–4 (poster).Keller M., Schuschnig U., Knoch M. et al. Characterization of nebulized Pulmozyme® administered by the PARI SINUS™ utilizing a human cast model. NACF. 2006; 1–4 (poster).Ушакова С.Г., Белавина П.И., Симонова О.И. Новая методика терапии хронического пансинусита у детей с муковисцидозом. Вопросы современной педиатрии. 2010; 9 (5): 72–79.Ушакова С.Г., Белавина П.И., Симонова О.И. Новая методика терапии хронического пансинусита у детей с муковисцидозом. Вопросы современной педиатрии. 2010; 9 (5): 72–79.Ашерова И.К. Рецидивирующий полисинусит как ведущий клинический признак муковисцидоза. Успешное эндоназальное применение Пульмозима. Педиатрическая фармакология. 2009; 6 (5): 90–93.Ашерова И.К. Рецидивирующий полисинусит как ведущий клинический признак муковисцидоза. Успешное эндоназальное применение Пульмозима. Педиатрическая фармакология. 2009; 6 (5): 90–93.Nishioka G.J., Barbero G.J., König P. et al. Symptom outcome after functional endoscopic sinus surgery in patients with cystic fibrosis: a prospective study. Otolaryngol. Head. Neck. Surg. 1995; 113 (4): 440–445.Nishioka G.J., Barbero G.J., König P. et al. Symptom outcome after functional endoscopic sinus surgery in patients with cystic fibrosis: a prospective study. Otolaryngol. Head. Neck. Surg. 1995; 113 (4): 440–445.Keck T., Rozsasi A. Medium-term symptom outcomes after paranasal sinus surgery in children and young adults with cystic fibrosis. Laryngoscope. 2007; 117: 475–479.Keck T., Rozsasi A. Medium-term symptom outcomes after paranasal sinus surgery in children and young adults with cystic fibrosis. Laryngoscope. 2007; 117: 475–479.
The authors declare that there are no conflicts of interest present.